Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Cracking the Marketing Conversion Barrier
-
AHF’s Charlie Chaplin Float in 2025 Rose Parade® Brings It ‘Home Sweet Home’
-
CI Global Asset Management Announces Confirmed Annual Reinvested Capital Gains Distributions for CI ETFs
-
New Year, New Discoveries: Save Up to $750 on All 2025 Trips with Grand Circle Corporation
-
SES AI to Participate at 2025 CES Show
-
Shamikhat Al-Sheqah, owned by Ibrahim Al-Muhaidib, Claims Al-Shaddad Award and the Title of "Munqiyat Al-Jazeera"
-
Maiden Holdings and Kestrel Group Announce Combination
-
Precigen Completes Submission of BLA with Request for Priority Review to the FDA for PRGN-2012 for the Treatment of Adults with Recurrent Respiratory Papillomatosis
-
American Lithium Announces Trading On the OTCQX Market
-
Southeastern Grocers highlights year of impactful contributions and industry achievements
-
N-able Celebrates Several Prestigious Employee-Centered Awards to Close Out the Year
-
Wabtec Acquires Bloom Engineering to Strengthen its Heat Transfer and Energy Solution Portfolio
-
Chimerix Submits Dordaviprone New Drug Application for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma
-
Recognition of the American Society of Clinical Oncology (ASCO) of the Liver Protective Effect of Can-Fite’s anti-Cancer Drug Namodenoson
-
Brazil Potash (NYSE American: GRO) Converts Its Water Extraction Installation Licenses Into Full Operational Permits at Its Autazes Potash Project Located in the Amazonas State of Brazil
-
Axsome Therapeutics Announces Successful Completion and Results of Phase 3 Clinical Program of AXS-05 in Alzheimer’s Disease Agitation
-
Amplify ETFs Declares December Income Distributions for its Income ETFs
-
Incora Announces Confirmation of Plan of Reorganization
-
OTC Markets Group Welcomes American Lithium Corp. to OTCQX
-
Clough Global Opportunities Fund Section 19(a) Notice
-
OTC Markets Group Welcomes Acuren Corporation to OTCQX
-
Clough Global Equity Fund Section 19(a) Notice
-
Orion and Marinus terminate agreement for ganaxolone in Europe
-
Clough Global Dividend and Income Fund Section 19(a) Notice
-
Reaves Utility Income Fund Section 19(A) Notice
-
Invesco Ltd: Form 8.3 - International Paper Co; Public dealing disclosure
-
Knowles Corporation Completes the Sale of Its Consumer MEMS Microphone Business to Syntiant
-
CI Financial Reports Total Assets of $532.7 Billion for November 2024
-
Southland Announces $20 Million Conversion of Promissory Notes Due to Management to Common Stock
-
China's role in economic globalization
-
Vanguard Announces Final Cash Distributions for the Vanguard ETFs
-
Vanguard Investments Canada Announces Final 2024 Annual Capital Gains Distributions for the Vanguard ETFs®
-
Bitget Introduces PoolX Winter Carnival with 15,440 BGB in Rewards
-
Bitget Completes First-Ever Burn of 800 Million BGB Tokens, Reducing Supply by 40%
-
Halozyme Announces argenx's VYDURA with ENHANZE® was Granted Regulatory Approval in Japan for Chronic Inflammatory Demyelinating Polyneuropathy
-
Target Hospitality Advances Growth Priorities with Strategic Hire
-
Guardian Metal Resources PLC Announces Pilot Mountain Drilling Update
-
Hola Prime Establishes Industry's First Dedicated Risk Compliance Team
-
Hola Prime Establishes Industry's First Dedicated Risk Compliance Team
-
Arkema: Disclosure of Trading in Own Shares from 23 December to 27 December 2024
-
ASPI CLASS ACTION NOTICE: Berger Montague Encourages ASP Isotopes (ASPI) Investors to Inquire About a Securities Fraud Class Action
-
Jeffs’ Brands Announces Drone Safety Systems Now Available on Amazon US
-
Radisson Announces Exercise of Warrants
-
Jaguar Mining Provides Update on Progress Since the Previously Announced Incident at the Satinoco Tailings Pile
-
NEVADA KING REVIEWS 2024 HIGHLIGHTS AND DETAILS DRILL PLAN FOR 2025 TO FOLLOW UP ON RECENT DISCOVERIES AND TEST NEW TARGETS AT ATLANTA
-
Halozyme Announces FDA Approval of Bristol Myers Squibb's Opdivo Qvantig™ with ENHANZE® for Subcutaneous Use in Most Previously Approved Adult Solid Tumor Opdivo® (nivolumab) Indications
-
Polyrizon Announces Publication of U.S. National Patent Application for Its Innovative Hydrogel Nasal Technologies
-
HSBC Bank Plc - Form 8.5 (EPT/RI) - Learning Technologies Group plc
-
Equinor ASA: Share buy-back
-
Fixing of coupon rates - Nykredit Realkredit A/S

